The Effects of Demographic and Clinical Data of Patients on Cerebral Oxygen Monitoring Values
1 other identifier
observational
80
1 country
1
Brief Summary
The aim of this study is to examine the effects of patients' clinical and demographic datas on cerebral oxygen saturation values. Brain oxygenation is measured using near infrared spectroscopy (NIRS). The primary outcome measure of the study is the regional oxygen saturation (rSO2) values measured on the monitor at twelve time points. The other primary outcome measures consist of baseline arterial and venous blood gas analysis and baseline activated clotting time measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2025
CompletedFirst Submitted
Initial submission to the registry
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
November 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 7, 2026
January 1, 2026
8 months
September 30, 2025
January 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Regional oxygen saturation values
Regional oxygen saturation values measurement at twelve points.
Baseline and peroperative measurements until the and of surgery
Baseline arterial blood gas analysis
The baseline arterial blood gas sample taken from the patient after arterial cannulation
Within 5 minutes after arterial cannulation for the baseline measurement
Venous blood gas analysis
Venous blood gas sample taken from the patient after central jugular venous cannulation
Within 5 minutes after central jugular venous cannulation
Baseline activated clotting time measurement
The baseline measurement of activated clotting time after arterial cannulation
Within 5 minutes after arterial cannulation for the baseline measurement
Eligibility Criteria
Patients undergoing elective coronary artery bypass grafting surgery
You may qualify if:
- Accepting to participate in the study
- Undergoing elective coronary artery bypass grafting surgery
- Age 25-80 years Ejection fraction 30% and above
You may not qualify if:
- Non volunteers
- Age \<25 or \>80 years
- Ejection fraction below 30%
- Patients with history of neurological disease or neurosurgery
- Emergency surgery
- Concurrent valve surgery
- Patients with history of carotid artery stenosis
- Patients with need for preoperative intraaortic balloon pump or inotropic support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tuna Şahinlead
Study Sites (1)
Tuna Şahin
Adana, Yüreğir, 01370, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Anesthesiologist
Study Record Dates
First Submitted
September 30, 2025
First Posted
November 14, 2025
Study Start
May 12, 2025
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
January 7, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share